Tinzaparin vs Warfarin for Acute Venous Thromboembolism

被引：1
|
作者：
Maruyama, Anna [1 ]
Tejani, Aaron M. [2 ]
Perry, Thomas L. [2 ]
机构：
[1] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Therapeut Initiat, Vancouver, BC V6T 1Z3, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 02期
关键词：
D O I：
10.1001/jama.2015.15067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [41] Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study
    Perez-de-Llano, Luis A.
    Leiro-Fernandez, Virginia
    Golpe, Rafael
    Nunez-Delgado, Jose M.
    Palacios-Bartolome, Ana
    Mendez-Marote, Lidia
    Colome-Nafria, Esteve
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (08) : 744 - 749
  • [42] Lengthened activated partial thromboplastin time in patients treated with tinzaparin for venous thromboembolism
    Achkar, A
    Horellou, MH
    Conard, J
    Laaban, JP
    Samama, MM
    PRESSE MEDICALE, 1998, 27 (14): : 667 - 668
  • [43] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    PLOS ONE, 2022, 17 (09):
  • [44] Safety and Efficacy of Direct Oral Anticoagulants vs Warfarin in Patients With Obesity and Venous Thromboembolism: A Retrospective Analysis
    Tu, Zoe H.
    Perez, Alejandro D.
    Diaz, Thomas E.
    Loop, Matthew S.
    Clarke, Megan
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [45] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1941 - 1941
  • [46] Management of Venous Thromboembolism in Morbid Obesity With Rivaroxaban or Warfarin
    Weaver, Paige
    Ng, Tsz Hin
    Breeden, Thomas
    Edwin, Stephanie B.
    Haan, Bradley
    Giuliano, Christopher
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (12) : 1315 - 1324
  • [47] Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin
    Marshall, Ariela L.
    Campigotto, Federico
    Neuberg, Donna
    Rowe, Betty
    Connors, Jean M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (07) : 632 - 638
  • [48] Patterns and Predictors of Warfarin Use in Patients with Venous Thromboembolism
    Deitelzweig, Steven B.
    Hussein, Mohamed
    Lin, Jay
    Kreilick, Charles
    Battleman, David
    BLOOD, 2008, 112 (11) : 1040 - 1040
  • [49] Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
    Majeed, Ammar
    Goldhaber, Samuel Z.
    Kakkar, Ajay
    Kearon, Clive
    Eriksson, Henry
    Kreuzer, Joerg
    Feuring, Martin
    Hantel, Stephan
    Friedman, Jeffrey
    Schellong, Sebastian
    Schulman, Sam
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 291 - 298
  • [50] Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
    Schulman, Sam
    Goldhaber, Samuel Z.
    Kearon, Clive
    Kakkar, Ajay K.
    Schellong, Sebastian
    Eriksson, Henry
    Hantel, Stefan
    Feuring, Martin
    Kreuzer, Joerg
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 150 - 157
12345